Novel TLR2-binding adjuvant induces enhanced T cell responses and tumor eradication
Abstract Background Ligands for the Toll-like receptor (TLR) family can induce activation of cells of the innate immune system and are widely studied for their potential to enhance adaptive immunity. Conjugation of TLR2-ligand Pam3CSK4 to synthetic long peptides (SLPs) was shown to strongly enhance...
Main Authors: | Gijs G. Zom, Marian M. J. H. P. Willems, Selina Khan, Tetje C. van der Sluis, Jan Willem Kleinovink, Marcel G. M. Camps, Gijsbert A. van der Marel, Dmitri V. Filippov, Cornelis J. M. Melief, Ferry Ossendorp |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2018-12-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40425-018-0455-2 |
Similar Items
-
Cationic Nanoparticle-Based Cancer Vaccines
by: Jeroen Heuts, et al.
Published: (2021-04-01) -
The Eradication of Smallpox in Bahrain
by: Mohamed Qasim Toorani
Published: (2016-02-01) -
Circulating vaccine-derived poliovirus: a menace to the end game of polio eradication
by: Long Chiau Ming, et al.
Published: (2020-07-01) -
Post-polio eradication: vaccination strategies and options for India
by: Jayakrishnan Thayyil, et al.
Published: (2014-11-01) -
PROBLEMS OF FINAL PHASE POLIOMYELITIS ERADICATION PROGRAMME
by: O. P. Chernyavskaya, et al.
Published: (2017-08-01)